UNIVERSAL HEALTH REALTY INCOME TRUST

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $17.2m $45.6m $24.2m $19.0m $19.4m $109.2m $21.1m $15.4m $19.2m $17.6m
Depreciation, Depletion and Amortization $23.0m $25.1m $24.8m $25.7m $25.6m $27.5m $26.6m $27.7m $27.4m $28.9m $28.8m
Amortization of Debt Issuance Costs $764k $791k $714k $729k $765k $762k
Amortization of Intangible Assets $5.1m $4.9m
Depreciation $17.4m $19.7m $20.5m $21.8m $21.8m $23.9m $23.3m $24.6m $24.5m $26.0m $28.8m
Depreciation Amortization Depletion $26.4m $27.6m $27.2m $28.7m $28.8m
Share-based Payment Arrangement, Noncash Expense $481k $538k $571k $702k $912k $947k $780k $780k $853k $936k $903k
Income (Loss) from Equity Method Investments $4.5m $2.4m $1.8m $1.8m $1.7m $1.8m $1.2m $1.2m $1.3m $1.7m
Change In Working Capital ($228k) $16k $82k $3.0m $673k
Change In Receivables ($2.1m) ($513k) ($760k) ($458k) ($143k)
Changes In Account Receivables ($2.1m) ($513k) ($760k) ($458k) ($143k)
Change In Payables And Accrued Expense $1.1m ($199k) ($105k) $2.3m ($1.0m)
Change In Accrued Expense $1.1m ($199k) ($105k) $2.3m ($1.0m)
Net Cash Provided by (Used in) Operating Activities $40.7m
$46.0m +12.94%
$42.9m -6.69%
$42.7m -0.64%
$44.2m +3.65%
$47.7m +7.95%
$46.8m -1.93%
$42.9m -8.26%
$46.9m +9.25%
$49.1m +4.65%
$48.2m -1.92%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $60.4m $9.0m $4.1m $5.1m $2.3m $13.0m $13.6m $7.6m ($22k)
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $87.3m ($232k) $232k
Payments to Acquire Investments $5.5m $532k $820k $2.1m $3.2m $16.8m $94k $4.1m $5.9m $6.8m
Net Other Investing Changes ($5.8m) ($1.3m) $3.5m ($128k)
Net Cash Provided by (Used in) Investing Activities ($74.8m) $39.5m ($8.0m) ($16.5m) ($27.2m) ($24.4m) ($36.7m) ($19.1m) ($13.9m) ($15.0m) ($16.6m)
Cash flows from financing activities:
Issuance Of Debt $26.2m $28.5m $22.3m $7.3m $10.8m
Long Term Debt Issuance $26.2m $28.5m $22.3m $7.3m $10.8m
Long Term Debt Payments ($12.2m) ($11.9m) ($13.6m) ($940k) ($588k)
Net Issuance Payments Of Debt $14.0m $16.6m $8.8m $6.4m $10.2m
Net Long Term Debt Issuance $14.0m $16.6m $8.8m $6.4m $10.2m
Net Short Term Debt Issuance $35.7m $26.2m $28.5m
Repayment Of Debt ($12.2m) ($11.9m) ($13.6m) ($940k) ($588k)
Payments for Repurchase of Common Stock $221k $235k
Common Stock Dividend Paid ($39.2m) ($39.8m) ($40.4m) ($41.0m) ($41.4m)
Common Stock Issuance $215k $177k $147k ($131k) $156k $100k
Common Stock Payments $0 $0 ($131k) ($131k)
Issuance Of Capital Stock $215k $177k $147k $156k $100k
Repurchase Of Capital Stock $0 $0 ($131k) ($131k)
Dividends paid $35.1m $36.1m $36.8m $37.4m $38.0m $38.5m $39.2m $39.8m $40.4m $41.0m ($41.4m)
Cash Dividends Paid ($39.2m) ($39.8m) ($40.4m) ($41.0m) ($41.4m)
Dividends Received CFI $875k $757k $1.1m $683k $789k
Net Other Financing Charges ($26k) ($222k) ($2.4m) ($35k) ($35k)
Net Cash Provided by (Used in) Financing Activities $34.1m
($86.0m) -351.95%
($33.3m) +61.26%
($25.1m) +24.65%
($17.4m) +30.81%
($6.5m) +62.36%
($25.0m) -282.76%
($23.2m) +7.17%
($34.1m) -47.00%
($34.5m) -1.16%
($31.3m) +9.36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1.6m $1.1m ($368k) $16.8m ($14.9m) $598k ($1.1m) ($411k) $6.8m
Beginning Cash Position $22.5m $7.6m $8.2m $7.1m $6.6m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Payments of Financing Costs $307k $446k $1.7m $35k $467k $1.8m $26k $222k $2.4m $35k
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $8.9m $9.7m $9.5m $10.0m $7.6m $8.1m $10.4m $16.3m $17.9m $17.9m
Additional Financial Items
Gains (Losses) on Sales of Investment Real Estate $2.0m
Operating Lease, Expense $460k $474k $480k $480k $508k $611k $666k $692k $723k
Cash Flow From Continuing Financing Activities ($25.0m) ($23.2m) ($34.1m) ($34.5m) ($31.3m)
Cash Flow From Continuing Investing Activities ($36.7m) ($19.1m) ($13.9m) ($15.0m) ($16.6m)
Change In Cash Supplemental As Reported ($14.9m) $598k ($1.1m) ($411k)
Change In Interest Payable $27k $117k $204k $216k ($29k)
Change In Other Working Capital $723k $728k $947k $1.1m $1.8m
Changes In Cash ($14.9m) $598k ($1.1m) ($411k) $265k
End Cash Position $7.6m $8.2m $7.1m $6.7m $6.8m
Financing Cash Flow ($25.0m)
($23.2m) +7.17%
($34.1m) -47.00%
($34.5m) -1.16%
($31.3m) +9.36%
Free Cash Flow $46.8m $42.9m $46.9m $49.1m $48.2m
Gain Loss On Investment Securities ($87.3m) $232k $232k
Investing Cash Flow ($36.7m) ($19.1m) ($13.9m) ($15.0m) ($16.6m)
Net Business Purchase And Sale ($94k) ($4.1m) ($5.9m) ($6.8m) ($191k)
Net Investment Properties Purchase And Sale ($36.1m) ($19.3m) ($9.1m) ($8.8m) ($18.2m)
Net PPE Purchase And Sale $15.1m ($13.6m) ($3.7m) $3.9m
Operating Gains Losses ($87.3m) $232k $232k
Other Non Cash Items ($1.3m) ($1.1m) ($503k) ($1.1m)
Purchase Of Business ($94k) ($4.1m) ($5.9m) ($6.8m) ($191k)
Purchase Of Investment Properties ($36.1m) ($23.2m) ($9.1m) ($8.8m) ($18.2m)
Purchase Of PPE $60.4m $9.0m $4.1m $5.1m $2.3m ($13.0m) ($13.6m) ($7.6m) $7.6m $7.6m ($22k)
Sale Of Investment Properties $0 $3.9m $0 $0 $0
Sale Of PPE $28.1m $0 $3.9m
Stock Based Compensation $780k $780k $853k $936k $903k